The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr Chhavi Saini (Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA) as well as the clinical implications of these findings, and what further study is needed.
The presentation entitled ‘Clinical Outcomes of Boston Keratoprosthesis Type II – Results from the Current Click-on Model’ was presented at the American Society of Cataract and Refractive Surgery, April 22-26, 2022
- Could you tell us a little about the Boston Keratoprosthesis type II (BK2) device and its advantages compared with the previous model?
- What were the aims and design of your study?
- What were the findings in terms of visual outcomes and complications?
- On the basis of these findings, what factors should be considered when assessing patient suitability for the current BK2 device?
- What questions remain unanswered and what further research is needed?
Disclosures: Chhavi Saini discloses grant/research support from Boston Keratoprosthesis Fund.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the virtual ASCRS 2022.
Share this Video
Related Videos In Ocular Surface Disease
Chhavi Saini, ASCRS 2022: Clinical outcomes of Boston keratoprosthesis type 2
The Boston Keratoprosthesis type II (BK2) device may be the only viable option to salvage vision in patients with severe cicatrizing ocular surface disease. The prior BK2 model was modified to the present day (click-on) model in 2009. The clinical outcomes of the current click-on BK2 model is discussed in this touchOPHTHALMOLOGY interview with Dr […]
Marie Bannier-Hélaouët, ESCRS 2021: Lacrimal Gland Organoids
It was a pleasure to interview Marie Bannier-Hélaouët (Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences, Utrecht, Netherlands) about her fascinating research into lachrymal gland organoids, which have great potential for the future treatment of lachrymal gland dysfunction. Questions What are the consequences of lachrymal gland dysfunction, and what have been the limitations in […]
Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye
Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!